B. Khor, A. Gardet, and R. J. Xavier, Genetics and pathogenesis of inflammatory bowel disease, Nature, vol.474, issue.7351, pp.307-317, 2011.

C. Abraham and J. H. Cho, Inflammatory bowel disease, N Engl J Med, vol.361, issue.21, pp.2066-2078, 2009.

S. Danese and C. Fiocchi, Ulcerative colitis, N Engl J Med, vol.365, issue.18, pp.1713-1725, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01707812

D. C. Baumgart and W. J. Sandborn, Crohn's disease, Lancet, vol.380, issue.9853, pp.1590-1605, 2012.

R. Ungaro, S. Mehandru, P. B. Allen, L. Peyrinbiroulet, and J. F. Colombel, Ulcerative colitis, Lancet, vol.389, pp.1756-1770, 2017.

J. Torres, S. Mehandru, J. F. Colombel, and L. Peyrinbiroulet, Crohn's disease, Lancet, vol.389, pp.1741-1755, 2017.

M. Allez, Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects, J Crohns Colitis, vol.4, issue.4, pp.355-366, 2010.

D. H. Adams and B. Eksteen, Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease, Nat Rev Immunol, vol.6, issue.3, pp.244-251, 2006.

W. W. Agace, Tissue-tropic effector T cells: generation and targeting opportunities, Nat Rev Immunol, vol.6, issue.9, pp.682-692, 2006.

B. G. Feagan, Vedolizumab as induction and maintenance therapy for ulcerative colitis, N Engl J Med, vol.369, issue.8, pp.699-710, 2013.

W. J. Sandborn, Vedolizumab as induction and maintenance therapy for Crohn's disease, N Engl J Med, vol.369, issue.8, pp.711-721, 2013.

C. L. Mackall, T. J. Fry, and R. E. Gress, Harnessing the biology of IL-7 for therapeutic application, Nat Rev Immunol, vol.11, issue.5, pp.330-342, 2011.

R. Mazzucchelli and S. K. Durum, Interleukin-7 receptor expression: intelligent design, Nat Rev Immunol, vol.7, issue.2, pp.144-154, 2007.

W. Liu, CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4

+. Cells, J Exp Med, vol.203, issue.7, pp.1701-1711, 2006.

N. Seddiki, Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells, J Exp Med, vol.203, issue.7, pp.1693-1700, 2006.

L. Michel, Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysis, J Clin Invest, vol.118, issue.10, pp.3411-3419, 2008.

Y. Rochman, R. Spolski, and W. J. Leonard, New insights into the regulation of T cells by gamma(c) family cytokines, Nat Rev Immunol, vol.9, issue.7, pp.480-490, 2009.

A. Pandey, Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin, Nat Immunol, vol.1, issue.1, pp.59-64, 2000.

F. Carrette and C. D. Surh, IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis, Semin Immunol, vol.24, issue.3, pp.209-217, 2012.

H. Dooms, Interleukin-7: fuel for the autoimmune attack, J Autoimmun, vol.45, pp.40-48, 2013.

H. L. Mai, IL-7 receptor blockade following T cell depletion promotes long-term allograft survival, J Clin Invest, vol.124, issue.4, pp.1723-1733, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-02167811

G. Piotti, J. Ma, A. E. Cobbold, S. Waldmann, and H. , Guiding postablative lymphocyte reconstitution as a route toward transplantation tolerance, Am J Transplant, vol.14, issue.7, pp.1678-1689, 2014.

S. Shalapour, Commensal microflora and interferon-gamma promote steady-state interleukin-7 production in vivo, Eur J Immunol, vol.40, issue.9, pp.2391-2400, 2010.

S. Shalapour, Interleukin-7 links T lymphocyte and intestinal epithelial cell homeostasis, PLoS One, vol.7, issue.2, p.31939, 2012.

M. Watanabe, Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa, J Exp Med, vol.187, issue.3, pp.389-402, 1998.

M. Yamazaki, Mucosal T cells expressing high levels of IL-7 receptor are potential targets for treatment of chronic colitis, J Immunol, vol.171, issue.3, pp.1556-1563, 2003.

E. Okada, IL-7 exacerbates chronic colitis with expansion of memory IL-7R high CD4 + mucosal T cells in mice, Am J Physiol Gastrointest Liver Physiol, vol.288, issue.4, pp.745-754, 2005.

T. Totsuka, IL-7 is essential for the development and the persistence of chronic colitis, J Immunol, vol.178, issue.8, pp.4737-4748, 2007.

T. Shinohara, Upregulated IL-7 receptor ? expression on colitogenic memory CD4

, + T cells may participate in the development and persistence of chronic colitis, J Immunol, vol.186, issue.4, pp.2623-2632, 2011.

S. Buonocore, Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology, Nature, vol.464, issue.7293, pp.1371-1375, 2010.

J. H. Bernink, Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues, Nat Immunol, vol.14, issue.3, pp.221-229, 2013.

R. Goldberg, N. Prescott, G. M. Lord, T. T. Macdonald, and N. Powell, The unusual suspects -innate lymphoid cells as novel therapeutic targets in IBD, Nat Rev Gastroenterol Hepatol, vol.12, issue.5, pp.271-283, 2015.

N. Powell, The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor + innate lymphoid cells, Immunity, vol.37, issue.4, pp.674-684, 2012.

C. R. Willis, Interleukin-7 receptor blockade suppresses adaptive and innate inflammatory responses in experimental colitis, J Inflamm (Lond), vol.9, issue.1, p.39, 2012.

M. F. Neurath, Cytokines in inflammatory bowel disease, Nat Rev Immunol, vol.14, issue.5, pp.329-342, 2014.

T. T. Macdonald, P. Biancheri, M. Sarra, and G. Monteleone, What's the next best cytokine target in IBD?, Inflamm Bowel Dis, vol.18, issue.11, pp.2180-2189, 2012.

H. S. De-souza and C. Fiocchi, Immunopathogenesis of IBD: current state of the art, Nat Rev Gastroenterol Hepatol, vol.13, issue.1, pp.13-27, 2016.

M. Watanabe, Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes, J Clin Invest, vol.95, issue.6, pp.2945-2953, 1995.

C. A. Anderson, Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47, Nat Genet, vol.43, issue.3, pp.246-252, 2011.

J. C. Lee, Gene expression profiling of CD8 + T cells predicts prognosis in patients with Crohn disease and ulcerative colitis, J Clin Invest, vol.121, issue.10, pp.4170-4179, 2011.

N. Planell, Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations, Gut, vol.62, issue.7, pp.967-976, 2013.

W. Vanhove, Strong upregulation of AIM2 and IFI16 inflammasomes in the mucosa of patients with active inflammatory bowel disease, Inflamm Bowel Dis, vol.21, issue.11, pp.2673-2682, 2015.

G. Toedter, Gene expression profiling and response signatures associated with differential responses to infliximab treatment in ulcerative colitis, Am J Gastroenterol, vol.106, issue.7, pp.1272-1280, 2011.
DOI : 10.1038/ajg.2011.83

Y. Haberman, Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature, J Clin Invest, vol.124, issue.8, pp.3617-3633, 2014.
DOI : 10.1172/jci79657

URL : http://www.jci.org/articles/view/79657/files/pdf

I. Arijs, Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis, Gut, vol.58, issue.12, pp.1612-1619, 2009.
DOI : 10.1136/gut.2009.178665

URL : https://gut.bmj.com/content/58/12/1612.full.pdf

I. Arijs, Mucosal gene expression of antimiafter first infliximab treatment, PLoS One, vol.4, issue.11, p.7984, 2009.
DOI : 10.1371/journal.pone.0007984

URL : https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0007984&type=printable

I. Arijs, Effect of vedolizumab (anti-? 4 ? 7 -integrin) therapy on histological healing and mucosal gene expression in patients with UC, Gut, vol.67, issue.1, pp.43-52, 2018.

N. R. West, Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease, Nat Med, vol.23, issue.5, pp.579-589, 2017.

A. M. Newman, Robust enumeration of cell subsets from tissue expression profiles, Nat Methods, vol.12, issue.5, pp.453-457, 2015.

Å. K. Björklund, The heterogeneity of human CD127(+) innate lymphoid cells revealed by single-cell RNA sequencing, Nat Immunol, vol.17, issue.4, pp.451-460, 2016.

O. I. Koues, Distinct gene regulatory pathways for human innate versus adaptive lymphoid cells, Cell, vol.165, issue.5, pp.1134-1146, 2016.
DOI : 10.1016/j.cell.2016.04.014

URL : https://doi.org/10.1016/j.cell.2016.04.014

Y. Simoni, Human innate lymphoid cell subsets possess tissue-type based heterogeneity in phenotype and frequency, Immunity, vol.46, issue.1, pp.148-161, 2017.
DOI : 10.1016/j.immuni.2016.11.005

B. Krämer, Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy, PLoS Pathog, vol.13, issue.5, p.1006373, 2017.

G. Fornasa, Dichotomy of short and long thymic stromal lymphopoietin isoforms in inflammatory disorders of the bowel and skin, J Allergy Clin Immunol, vol.136, issue.2, pp.413-422, 2015.

L. Bjerkan, The short form of TSLP is constitutively translated in human keratinocytes and has characteristics of an antimicrobial peptide, Mucosal Immunol, vol.8, issue.1, pp.49-56, 2015.

N. K. Vudattu, I. Magalhaes, H. Hoehn, D. Pan, and M. J. Maeurer, Expression analysis and functional activity of interleukin-7 splice variants, Genes Immun, vol.10, issue.2, pp.132-140, 2009.

S. G. Gregory, Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis, Nat Genet, vol.39, issue.9, pp.1083-1091, 2007.

W. Lundström, Soluble IL7R? potentiates IL-7 bioactivity and promotes autoimmunity, Proc Natl Acad Sci U S A, vol.110, pp.1761-1770, 2013.

S. Beq, Injection of glycosylated recombinant simian IL-7 provokes rapid and massive T-cell homing in rhesus macaques, Blood, vol.114, issue.4, pp.816-825, 2009.

I. Sereti, Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration, PLoS Pathog, vol.10, issue.1, p.1003890, 2014.

R. Cimbro, IL-7 induces expression and activation of integrin ?4?7 promoting naive T-cell homing to the intestinal mucosa, Blood, vol.120, issue.13, pp.2610-2619, 2012.

X. Zhang, Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues, Proc Natl Acad Sci, vol.102, issue.12, pp.4459-4464, 2005.

A. Lesiak, A genome-wide screen of CREB occupancy identifies the RhoA inhibitors Par6C and Rnd3 as regulators of BDNF-induced synaptogenesis, PLoS One, vol.8, issue.6, p.64658, 2013.

N. Poirier, Preclinical efficacy and immunological safety of FR104, an antagonist anti-CD28 monovalent Fab? antibody, Am J Transplant, vol.12, issue.10, pp.2630-2640, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-02167934

A. Fischer, Differential effects of ?4?7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo, Gut, vol.65, issue.10, pp.1642-1664, 2016.

S. Wirtz, C. Neufert, B. Weigmann, and M. F. Neurath, Chemically induced mouse models of intestinal inflammation, Nat Protoc, vol.2, issue.3, pp.541-546, 2007.

P. Pelczar, A pathogenic role for T cellderived IL-22BP in inflammatory bowel disease, Science, vol.354, issue.6310, pp.358-362, 2016.

L. Rovedatti, Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease, Gut, vol.58, issue.12, pp.1629-1636, 2009.

E. Louis, Treatment of small bowel subocclusive Crohn's disease with infliximab: an open pilot study, Acta Gastroenterol Belg, vol.70, issue.1, pp.15-19, 2007.

J. R. De-bruyn, Intestinal fibrosis is associated with lack of response to Infliximab therapy in Crohn's disease, PLoS One, vol.13, issue.1, p.190999, 2018.

W. Zhang, J. Y. Du, Q. Yu, and J. O. Jin, Interleukin-7 produced by intestinal epithelial cells in response to Citrobacter rodentium infection plays a major role in innate immunity against this pathogen, Infect Immun, vol.83, issue.8, pp.3213-3223, 2015.

J. Imanishi, Expression of cytokines in bacterial and viral infections and their biochemical aspects, J Biochem, vol.127, issue.4, pp.525-530, 2000.

T. Glatzer, ROR?t+ innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44, Immunity, vol.38, issue.6, pp.1223-1235, 2013.

T. Tomita, IL-7 is essential for the persistence of chronic colitis, J Immunol, vol.180, issue.1, pp.383-390, 2008.

Y. Nemoto, Bone marrow-mesenchymal stem cells are a major source of interleukin-7 and sustain colitis by forming the niche for colitogenic CD4 memory T cells, Gut, vol.62, issue.8, pp.1142-1152, 2013.

M. Iwata, A. Hirakiyama, Y. Eshima, H. Kagechika, C. Kato et al., Retinoic acid imprints gut-homing specificity on T cells, Immunity, vol.21, issue.4, pp.527-538, 2004.

S. G. Kang, J. Park, J. Y. Cho, B. Ulrich, and C. H. Kim, Complementary roles of retinoic acid and TGF-?1 in coordinated expression of mucosal integrins by T cells, Mucosal Immunol, vol.4, issue.1, pp.66-82, 2011.

G. Bakdash, L. T. Vogelpoel, T. M. Van-capel, M. L. Kapsenberg, and E. C. De-jong, Retinoic acid primes human dendritic cells to induce gut-homing, IL-10-producing regulatory T cells, Mucosal Immunol, vol.8, issue.2, pp.265-278, 2015.

H. L. Zhang, Regulatory T-cell depletion in the gut caused by integrin ?7 deficiency exacerbates DSS colitis by evoking aberrant innate immunity, Mucosal Immunol, vol.9, issue.2, pp.391-400, 2016.

P. H. Thang, The role of IL-1? in reduced IL-7 production by stromal and epithelial cells: a model for impaired T-cell numbers in the gut during HIV-1 infection, J Intern Med, vol.268, issue.2, pp.181-193, 2010.

S. Sawa, Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4

. +-t-cells, J Exp Med, vol.203, issue.6, pp.1459-1470, 2006.

S. Giliani, Interleukin-7 receptor alpha (IL-7Ralpha) deficiency: cellular and molecular bases, Immunol Rev, vol.203, pp.110-126, 2005.

L. Belarif, IL-7 receptor blockade blunts antigen-specific memory T cell responses and chronic inflammation in primates, Nat Commun, vol.9, issue.1, p.4483, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-02023397

B. Kern, W. Li, C. Bono, L. F. Lee, and E. Kraynov, Receptor occupancy and blocking of STAT5 signaling by an anti-IL-7 receptor ? antibody in cynomolgus monkeys, Cytometry B Clin Cytom, vol.90, issue.2, pp.191-198, 2016.

J. Dunham, Blockade of CD127 exerts a dichotomous clinical effect in marmoset experimental autoimmune encephalomyelitis, J Neuroimmune Pharmacol, vol.11, issue.1, pp.73-83, 2016.

B. J. Ganguly, An IL-7 receptor blocking antibody increases the ratio of Tregs to effector memory T cells (TEM) and increases PD-1 expression on T cell subsets in the peripheral blood of patients with type 1 diabetes, 2016.